Invention Grant
- Patent Title: IL-11 muteins
- Patent Title (中): IL-11突变蛋白
-
Application No.: US12257565Application Date: 2008-10-24
-
Publication No.: US07993637B2Publication Date: 2011-08-09
- Inventor: Manuel Baca
- Applicant: Manuel Baca
- Applicant Address: AU Parkville, Victoria
- Assignee: CSL Limited
- Current Assignee: CSL Limited
- Current Assignee Address: AU Parkville, Victoria
- Agency: Scully, Scott, Murphy & Presser, P.C.
- Main IPC: C07K14/54
- IPC: C07K14/54 ; A61K38/20
Abstract:
The present invention relates generally to the treatment of an interleukin-11 (IL-11)-mediated condition. More particularly, the present invention provides the use of modified forms of IL-11 which modulate IL-11 signaling in the treatment of IL-11-mediated conditions.
Public/Granted literature
- US20090191148A1 CYTOKINE MUTEINS Public/Granted day:2009-07-30
Information query
